BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

WuXi Biologics Begins Construction of One of the World’s Largest Modular Biologics Drug Product Facilities in Singapore

Innovative modular design will accelerate construction and manufacturing timelines, enabling rapid adaptation of manufacturing capacities across diverse ...

July 30, 2025 | News

Bristol Myers Squibb and Bain Capital Launch New Biotech Company with $300M to Advance Autoimmune Therapies

Five immunology assets in-licensed from BMS with potential to address unmet needs for patients with autoimmune diseases, including late-stage asset for...

July 29, 2025 | News

Biocytogen Expands Preclinical Capabilities Across Asia and the U.S. with Over 1,000 Humanized Mouse Models

Biocytogen (HKEX: 02315), an international biotechnology company that drives new drug development with innovative technologies, announced that its pr...

July 29, 2025 | News

GNT Pharma Receives South Korea’s Green Light to Launch Global Phase 3 Trials for Breakthrough Stroke Drug Nelonemdaz

GNT Pharma, a late-stage biopharmaceutical company with operations in Seoul and New York, announced its IND Application to commence Glo...

July 25, 2025 | News

Precision Medicine – Are We Ready for It?

Sarthak Ranade, Area Managing Director of Johnson & Johnson Innovative Medicine for SEA and India, believes the era of precision medicine is no longer ...

July 23, 2025 | Opinion | By Sarthak Ranade, Area Managing Director, J&J Innovative Medicine, SEA & India

QIAGEN Expands QIAseq Portfolio with Launch of Long Read Panels to Enhance Complex Genomic Analysis

Expansion of QIAseq portfolio to Long Read Panels enables high-resolution analysis of complex genomic regions using long-read sequencing Supports NGS ...

July 23, 2025 | News

China’s DualityBio Secures FDA Fast Track for Next-Gen HER3 ADC DB-1310 in Advanced Lung Cancer

DualityBio announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to its next-generation HER3-targeting a...

July 23, 2025 | News

10x Genomics and A*STAR GIS Join Forces to Advance Precision Medicine Through AI-Powered Spatial Biology

10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, and the A*STAR Genome Institute of Singapore (A*STAR GIS), announced a resea...

July 21, 2025 | News

Hyphens Pharma Launches Winlevi® in Singapore and Malaysia, Ushering in a New Era of Acne Treatment in Southeast Asia

Hyphens Pharma Pte. Ltd., a subsidiary of SGX Catalist-listed Hyphens Pharma International Limited, Singapore’s leading specialty pharmaceutical...

July 18, 2025 | News

SK bioscience Pioneers Korea’s First Adjuvanted Flu Vaccine with IND Filing for NBP607B

Company aims for technology advancement and platform expansion with Korea's first influenza vaccine using an adjuvant Interim results from the Phase 1/2...

July 18, 2025 | News

SN BioScience’s Anticancer Candidate SNB-101 Selected for Korea’s 2025 National Drug Development Programme

SN BioScience announced that its anticancer candidate SNB-101 has been selected as a clinical-stage project under the 2025 Korea Drug Development Project, ...

July 17, 2025 | News

Taiwan’s Senhwa Biosciences’ CX-5461 Selected by U.S. National Cancer Institute for Major Oncology Research Programme

Senhwa Biosciences, Inc. (TPEx: 6492), a new drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious d...

July 16, 2025 | News

Amarna Therapeutics and NorthX Biologics Advance Nimvec™ AM510 Toward Clinical Trials for Type 1 Diabetes

Fast-Tracking Clinical Readiness: The agreement enables process and analytical development activities required to advance Nimvec™ AM510 for Type 1 ...

July 14, 2025 | News

Elegen and Nutcracker Therapeutics Launch Cell-Free Platform Pilot to Transform RNA-Based Personalised Cancer Therapeutics

Elegen, a global leader in next-generation DNA manufacturing, and Nutcracker Therapeutics, a global leader in next-generation RNA design and manufactu...

July 14, 2025 | News

Stay Connected